Pyramidion Technology Group

• 

  Pyramidion Technology Group, Inc. (OTC: “PYTG”) Strengthens Board of Advisors With the Appointment of Dr. David M. Feldbaum

  9:02 AM|September 12, 2018

  WESTON, Florida, September 12, 2018 /PRNewswire/ — Pyramidion Technology Group, Inc. (OTC: PYTG) today announces that Dr. David M. Feldbaum MD, Fellow, American College of Surgeons (FACS), has been appointed to the Board of Advisors for PYTG. David M. Feldbaum MD, FACS is certified in vascular surgery by the American Board of Surgery. Dr. Feldbaum completed a surgical residency at Montefiore Medical Center/Albert Einstein College of Medicine in New York City, and a vascular surgery fellowship at the Carolinas Heart Institute in North Carolina. He is affiliated with

  Read more
• 

  Pyramidion Technology Group, Inc. (OTC: ‘PYTG’) Enters Into a Letter of Intent to Acquire NxGen Brands, LLC

  2:53 PM|August 29, 2018

  Deal is company’s first in line of acquiring companies that will deliver alternative medicine to Patients with Critical Conditions using Cannabinoids (CBD) Infused Products. WESTON, Florida, August 28, 2018 /PRNewswire/ — Pyramidion Technology Group, Inc (or the “Company”) (OTC: PYTG), today announced the execution of a binding letter of intent to acquire NxGen Brands, LLC its web-portal http://www.LeafyWell.com of Denver, Colorado, one of the area’s most well-known and successful CBD Marketing Groups (“NxGen”). Pursuant to the letter of Intent, PYTG will be

  Read more
• 

  Pyramidion Technology Group, Inc. (PYTG) Plans to Enter CBD or Cannabidiol Market Which Forbes Estimates $2.1 to $3 Billion by 2020

  12:21 PM|August 17, 2018

  Company In Process Of Negotiating An Acquisition Of A Company That Markets Cannabidiol (CBD) Based Products PR Newswire  WESTON, Florida  /PRNewswire/ — Pyramidion Technology Group, Inc. (“PYTG”, or the “Company”) (OTC PINK: PYTG), today announced that it plans to enter the CBD based products market and is looking to acquire a company that markets premium quality independently certified all-natural wellness products, as part of its plan to become a global cannabis industry leader dedicated to the research, development, and the multi-national

  Read more

• (CFMI.OB) China Pharmaceuticals Announces Launch of New Website

  1:00 AM|May 11, 2010

  “It is our expectation that with its fresh appearance and user-friendly design, our new website will be instrumental in providing an effective platform for the dissemination of news, updates, webcasts, and pertinent shareholder and investor relations information concerning the company.”

  Read more

• 4/21 (CFMI.OB) China Pharmaceuticals Announces Record Fiscal Year 2009 Results

  1:00 AM|April 21, 2010

  “We are focused on continuing to expand our portfolio of high margin products that address major disease categories and on continuing to build sustainable growth in revenues and profits.”

  Read more